Vincent Rajkumar: Trials with bispecifics for myeloma going on in all stages of the disease
Vincent Rajkumar/X

Vincent Rajkumar: Trials with bispecifics for myeloma going on in all stages of the disease

Vincent Rajkumar shared on X:

”Trials with bispecifics for myeloma going on in all stages of the disease. A nice summary slide thanks to Tom Martin.”

International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma

Authors: S Vincent Rajkumar, Meletios A Dimopoulos, Antonio Palumbo, Joan Blade, Giampaolo Merlini, María-Victoria Mateos, Shaji Kumar, Jens Hillengass, Efstathios Kastritis, Paul Richardson, Ola Landgren, Bruno Paiva, Angela Dispenzieri, Brendan Weiss, Xavier LeLeu, Sonja Zweegman, Sagar Lonial, Laura Rosinol, Elena Zamagni, Sundar Jagannath, Orhan Sezer, Sigurdur Y Kristinsson, Jo Caers, Saad Z Usmani, Juan José Lahuerta, Hans Erik Johnsen, Meral Beksac, Michele Cavo, Hartmut Goldschmidt, Evangelos Terpos, Robert A Kyle, Kenneth C Anderson, Brian G M Durie, Jesus F San Miguel.

Vincent Rajkumar: Trials with bispecifics for myeloma going on in all stages of the disease

Vincent Rajkumar: Trials with bispecifics for myeloma going on in all stages of the disease

Vincent Rajkumar is a Professor of Medicine at the Mayo Clinic in Rochester, Minnesota, and Chair for the Mayo Clinic Myeloma, Amyloidosis, and Dysproteinemia Group.  He also chairs the Board of directors of  The International Myeloma Foundation and the Eastern Cooperative Oncology Group (ECOG) Myeloma Committee.

His extensive contributions include over 230 peer-reviewed publications, predominantly focusing on multiple myeloma and related plasma cell disorders. Furthermore, Dr. Rajkumar is a Section Editor for multiple myeloma and related disorders for Leukemia and an Associate Editor for the Mayo Clinic Proceedings.